Objectives

After participating in this educational activity, attendees should be able to:
1| Define Category E pulmonary embolism under 2026 guidelines.
2| Compare evidence for standard vs reduced-dose alteplase strategies.
3| Evaluate bleeding risk and post-lysis management.

Presenter(s): 
Danielle Ellis, PharmD
PGY2 Critical Care Pharmacy Resident
Baystate Medical Center
 
NameRoleFinancial Relationship DisclosuresDiscussion of
Unlabeled/Unapproved Uses of
Drugs/Devices in Presentation?
Danielle Ellis, PharmDSpeaker/AuthorNo relevant relationships with ineligible companies to discloseNo
Session date: 
03/02/2026 - 2:00pm to 3:00pm EST
Location: 
Hybrid
United States
See map: Google Maps
Add to calendar: 
  • 1.00 ACPE Contact Hours
  • 1.00 ACPE Technician contact hours
Please login or register to take this course.